Jean-Pierre Garnier - CHAIRMAN OF THE BOARD
Jean-Pierre Garnier (d.o.b. 31 October 1947) has been Chairman of Actelion's Board of Directors since September 2011, following his election to the Board at the company's Annual General Meeting in May 2011.
From 2008 to 2010, Dr. Garnier was CEO of Pierre Fabre Labs, a pharmaceutical and dermocosmetical company located in France. From 2001 to 2008, Dr. Garnier was the first Chief Executive Officer of GlaxoSmithKline, assuming this role with the merger of SmithKline Beecham and Glaxo Wellcome. He joined SmithKline Beecham in 1990 as President of its pharmaceutical business in North America and served as Chairman, Pharmaceuticals from 1994 until his appointment as Chief Operating Officer in 1995. He was elected to the company's Board of Directors in 1992. He became Chief Executive Officer of SmithKline Beecham in April 2000.
Prior to SmithKline Beecham, Dr. Garnier served as President of Schering-Plough's US business. During his 15 years at Schering, he held various management positions, including General Manager of several overseas subsidiaries.
Dr. Garnier serves on the Boards of Directors of United Technologies Corporation, Renault S.A., Radius Health, Inc., and Alzheon, Inc., and acts as operating partner at Advent international, a global private equity firm.
Dr. Garnier’s accomplishments have been recognized with many prestigious appointments and awards. In 2001 he was presented with the Marco Polo Award for GlaxoSmithKline's commitment to China. In 2005, he was presented with the Global Business Leadership Award from Stanford Business School. In July 2007, he was appointed to the UK Prime Minister's Business Advisory Council. In 2007/2008 he was strategic advisor to the Dubai International Capital investment fund. In 1997, he received the Chevalier de la Légion d'Honneur and, in January 2008, he was promoted to Officier de Légion d’Honneur. In May 2009, he was appointed as “Knight Commander of the British Empire”.
Dr. Garnier holds a PhD in pharmacology and an MS in pharmaceutical science from the Louis Pasteur University of Strasbourg, France. As a Fulbright Scholar, he earned an MBA at Stanford University, California in 1974.